Covered recipient · General Payments record
JACK V GREINER
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$2,781.79
- Reported across 89 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $278.00 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $167.56 | 10 |
| BIOTISSUE HOLDINGS INC. | $47.65 | 3 |
| Mallinckrodt Hospital Products Inc. | $32.76 | 2 |
| Oyster Point Pharma, Inc. | $15.59 | 1 |
| Bausch & Lomb Americas Inc. | $14.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.83 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837340 | CMS |
| ABBVIE INC. | $19.24 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837342 | CMS |
| ABBVIE INC. | $11.14 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837344 | CMS |
| ABBVIE INC. | $9.28 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837346 | CMS |
| ABBVIE INC. | $8.97 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837348 | CMS |
| ABBVIE INC. | $28.30 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837350 | CMS |
| ABBVIE INC. | $9.88 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837352 | CMS |
| ABBVIE INC. | $23.71 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837354 | CMS |
| ABBVIE INC. | $13.79 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837356 | CMS |
| ABBVIE INC. | $20.42 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837358 | CMS |
| Bausch & Lomb Americas Inc. | $14.44 | 12/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140355630 | CMS |
| BIOTISSUE HOLDINGS INC. | $20.15 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148785229 | CMS |
| BIOTISSUE HOLDINGS INC. | $13.75 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148752899 | CMS |
| BIOTISSUE HOLDINGS INC. | $13.75 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148761733 | CMS |
| Mallinckrodt Hospital Products Inc. | $18.05 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145078367 | CMS |
| Mallinckrodt Hospital Products Inc. | $14.71 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145078371 | CMS |
| Oyster Point Pharma, Inc. | $15.59 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147436525 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.